Surgery for Galactorrhea: Indications, Procedure, and Outcomes

Surgical intervention for galactorrhea is reserved for cases caused by a prolactin-secreting pituitary adenoma (prolactinoma) when:

  • Medical therapy (dopamine agonists: cabergoline, bromocriptine) fails to normalize prolactin or control symptoms.
  • The tumor is large (macroadenoma ≥10 mm) or shows radiographic progression.
  • Visual field defects or cranial nerve compression develop.
  • Patient cannot tolerate medication side effects.

Surgical Approach: Endoscopic Transsphenoidal Surgery

  1. Under general anesthesia, an endoscope is introduced through the nostril.
  2. The sphenoid sinus is opened, exposing the sella turcica.
  3. The dura is incised; the adenoma is meticulously removed using micro-instruments.
  4. Autologous fat or synthetic graft may be used to reconstruct the sellar floor.
  5. Nasal packing or a vascularized nasoseptal flap may be placed for CSF leak prevention.

Outcomes and Follow-Up

  • Biochemical remission: 80–90% for microadenomas; 50–70% for macroadenomas.
  • Visual improvement: Majority regain fields if decompression is timely.
  • Recurrence: 10–20% at 10 years; higher for macroadenomas.

Multidisciplinary Care

Essential collaboration between neurosurgery, endocrinology, and neuro-ophthalmology for preoperative planning, postoperative hormone monitoring (prolactin, cortisol, thyroid, gonadal axes), and long-term surveillance MRI.

Surgery is safe and effective in experienced hands but is not first-line for most prolactinomas. Medical therapy remains the initial standard of care.

Gonorrhea - Related Articles